Question 1

Is Choriogonadotropine Alfa currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Choriogonadotropine Alfa has 3 active shortage notices across 2 countries (Netherlands, Canada). Status is refreshed daily from official regulatory sources.

Question 2

Why is Choriogonadotropine Alfa in shortage?

Accepted Answer

Regulators attribute the current Choriogonadotropine Alfa shortages to unexpected increases in demand. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

When will the Choriogonadotropine Alfa shortage be resolved?

Accepted Answer

Regulator-estimated resolution dates currently range from 30 Sept 2026 to 30 Sept 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.

Question 4

Where does this Choriogonadotropine Alfa shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.

Country	Severity	Notices	Since	Est. resolution	Source
Netherlands	medium	2	20 May 2026	—	CBG-MEB
Canada	medium	1	2 Sept 2024	30 Sept 2026	HC

Choriogonadotropine Alfa shortage status

Where Choriogonadotropine Alfa is in shortage

Why Choriogonadotropine Alfa is in shortage

Frequently asked questions

Get alerted when Choriogonadotropine Alfa status changes